Back
Adlai Nortye 10K Form
Sell
49
ANL
Adlai Nortye
Last Price:
13.74
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ANL News And Ratings
See the #1 stock for the next 7 days that we like better than ANL
ANL Financial Statistics
Sales & Book Value
| Annual Sales: | $5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.51970 |
|---|---|
| Net Income (TTM): | $-92.98M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Adlai Nortye Earnings Forecast
Key Adlai Nortye Financial Ratios
- The Research & Development expenses have been 1,163.04% of Revenue.
- The Interest Expense is -0.75% of Operating Income.
- The Net Earning history of ANL is -2,097.42% of Total Revenues.
- Per Share Earnings over the last 3 years have been positive in 0 years.
Adlai Nortye Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ANL |
| Website: | adlainortye.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANL Technical Analysis vs Fundamental Analysis
Sell
49
Adlai Nortye (ANL)
is a Sell
Is Adlai Nortye a Buy or a Sell?
-
Adlai Nortye stock is rated a Sell
The current Adlai Nortye [ANL] share price is $13.25. The Score for ANL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.